Advancements in CKD Management

This chapter covers the latest updates to chronic kidney disease (CKD) guidelines, emphasizing the role of cystatin C as a crucial biomarker for kidney function. It explores the complexity of managing hypertension in CKD patients, focusing on medication alternatives and the impact of individualized treatment strategies. The conversation also addresses challenges such as hyperkalemia and the integration of SGLT2 inhibitors, highlighting their benefits even in advanced stages of kidney disease.